Department of Pathology, Dr. B Borooah Cancer Institute, Guwahati, Assam, India.
Dr. B Borooah Cancer Institute, Guwahati, Assam, India.
J Cancer Res Ther. 2020 Oct-Dec;16(6):1371-1375. doi: 10.4103/jcrt.JCRT_402_19.
Breast cancer is commonly diagnosed cancer in women. Tumor receptors estrogen receptor (ER) and progesterone receptor (PR) are well recognized prognostic factors for breast cancer.
Data from the department of pathology for the 5-year period (2010 to 2014) is used for analysis for Kamrup district of Assam, India. Kaplan Meir method was used to evaluate survival rate.
The overall 5-year survival is observed as 54.6%. There is a 10.6% improvement in survival was recorded among those who living in the urban areas. The risk of death was 40% higher for those who were resides in rural areas compared to urban areas (P = 0.070). There is a 6 fold variation in survival was observed according to their stage at presentation. Hormone receptors found to be play an important role in survival outcome. Patients with ER/PR+ (positive) status have 13.6% higher survival rate than those with ER/PR-. The overall survival for ER/PR positive is 72.1% compared to 58.5% of ER/PR negative.
From the study it is observed that population with positive hormone receptors (ER/PR +) and living in the urban areas is experiencing survival rate.
乳腺癌是女性常见的癌症诊断。肿瘤受体雌激素受体(ER)和孕激素受体(PR)是公认的乳腺癌预后因素。
使用印度阿萨姆邦卡姆鲁普区 5 年(2010 年至 2014 年)的病理学部门数据进行分析。采用 Kaplan-Meier 法评估生存率。
总体 5 年生存率为 54.6%。居住在城市地区的患者生存率提高了 10.6%。与城市地区相比,农村地区患者的死亡风险高 40%(P=0.070)。根据就诊时的分期,生存率有 6 倍的差异。激素受体在生存结果中起着重要作用。ER/PR+(阳性)状态的患者生存率比 ER/PR-患者高 13.6%。ER/PR 阳性的总体生存率为 72.1%,而 ER/PR 阴性的生存率为 58.5%。
从研究中可以观察到,具有阳性激素受体(ER/PR+)和居住在城市地区的人群的生存率较高。